Literature DB >> 4729039

Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.

L Lemberger, R Martz, B Rodda, R Forney, H Rowe.   

Abstract

A comparison of the psychologic and physiologic effects of intravenously administered Delta(9)-tetrahydrocannabinol (Delta(9)-THC) and 11-hydroxy-Delta(9)-tetrahydrocannabinol (11-OH-Delta(9)-THC) was carried out in nine casual marihuana smokers. A marked tachycardia and psychologic "high" occurred within 3-5 min after the i.v. administration of 11-OH-Delta(9)-THC (1 mg) to all subjects. In contrast, the peak psychologic "high" was delayed 10-20 min after the i.v. administration of Delta(9)-THC (1 mg). There was some individual variation in response among subjects. Psychologic effects correlated well with plasma levels of unchanged [(3)H]11-OH-Delta(9)-THC. About 75% of the administered radioactive dose was excreted in urine (25%) and feces (50%) after [(3)H]11-OH-Delta(9)-THC administration. The disposition, excretion, and metabolism of [(3)H]11-OH-Delta(9)-THC appear to be similar to that previously reported after [(14)C]Delta(9)-THC administration. These findings, in conjunction with the marked psychologic high seen after 11-OH-Delta(9)-THC, suggest that in man, Delta(9)-THC, the active constituent in marihuana, is converted to 11-OH-Delta(9)-THC, which is in part responsible for the psychologic effects.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729039      PMCID: PMC302499          DOI: 10.1172/JCI107431

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

Review 1.  Marihuana chemistry.

Authors:  R Mechoulam
Journal:  Science       Date:  1970-06-05       Impact factor: 47.728

2.  Effects of (--)delta-9-trans-tetrahydrocannabinol in man.

Authors:  H Isbell; C W Gorodetzsky; D Jasinski; U Claussen; F von Spulak; F Korte
Journal:  Psychopharmacologia       Date:  1967

3.  Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration.

Authors:  L Lemberger; J L Weiss; A M Watanabe; I M Galanter; R J Wyatt; P V Cardon
Journal:  N Engl J Med       Date:  1972-03-30       Impact factor: 91.245

4.  Comparison of tetrahydrocannabinol and synhexyl in man.

Authors:  L E Hollister; R K Richards; H K Gillespie
Journal:  Clin Pharmacol Ther       Date:  1968 Nov-Dec       Impact factor: 6.875

5.  Identification through synthesis of an active delta-1(6)-tetrahydrocannabinol metabolite.

Authors:  Z Ben-Zvi; R Mechoulam; S Burstein
Journal:  J Am Chem Soc       Date:  1970-06-03       Impact factor: 15.419

Review 6.  Metabolism and disposition of delta-9-tetrahydrocannabinol in man.

Authors:  L Lemberger; J Axelrod; I J Kopin
Journal:  Pharmacol Rev       Date:  1971-12       Impact factor: 25.468

7.  Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.

Authors:  L Lemberger; S D Silberstein; J Axelrod; I J Kopin
Journal:  Science       Date:  1970-12-18       Impact factor: 47.728

8.  Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.

Authors:  M Perez-Reyes; M C Timmons; M A Lipton; K H Davis; M E Wall
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

9.  Metabolite of (-)-trans-delta 8-tetrahydrocannabinol: identification and synthesis.

Authors:  R L Foltz; A F Fentiman; F G Leighty; J L Walter; H R Drewes; W E Schwartz; T F Page; E B Truitt
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

10.  Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.

Authors:  H D Christensen; R I Freudenthal; J T Gidley; R Rosenfeld; G Boegli; L Testino; D R Brine; C G Pitt; M E Wall
Journal:  Science       Date:  1971-04-09       Impact factor: 47.728

View more
  12 in total

1.  Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

Authors:  Linda E Klumpers; Tim L Beumer; Johan G C van Hasselt; Astrid Lipplaa; Lennard B Karger; H Daniël Kleinloog; Jan I Freijer; Marieke L de Kam; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

2.  The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.

Authors:  Michelle Carbuto; R Andrew Sewell; Ashley Williams; Kim Forselius-Bielen; Gabriel Braley; Jacqueline Elander; Brian Pittman; Ashley Schnakenberg; Savita Bhakta; Edward Perry; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2011-08-16       Impact factor: 4.530

Review 3.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

4.  Metabolism and autoradiographic distribution of delta-8- and delta-9-tetrahydrocannabinol in some organs of the monkey Callithrix jacchus.

Authors:  W W Just; G Erdmann; S Thel; G Werner; M Wiechmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

5.  delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111.

Authors:  T U Järbe; D E McMillan
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects.

Authors:  Evan S Herrmann; Edward J Cone; John M Mitchell; George E Bigelow; Charles LoDico; Ron Flegel; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2015-04-06       Impact factor: 4.492

7.  Development and Verification of a Linked Δ 9-THC/11-OH-THC Physiologically Based Pharmacokinetic Model in Healthy, Nonpregnant Population and Extrapolation to Pregnant Women.

Authors:  Gabriela I Patilea-Vrana; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2021-05-05       Impact factor: 3.579

8.  Sex, species and age: Effects of rodent demographics on the pharmacology of ∆9-tetrahydrocanabinol.

Authors:  Jenny L Wiley; Daniel G Barrus; Charlotte E Farquhar; Timothy W Lefever; Thomas F Gamage
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-08-15       Impact factor: 5.067

9.  Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.

Authors:  Marcel O Bonn-Miller; Stan L Banks; Terri Sebree
Journal:  Cannabis Cannabinoid Res       Date:  2017-01-01

Review 10.  Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions.

Authors:  Joshua D Brown
Journal:  J Clin Med       Date:  2020-03-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.